There’s an interesting semantic discussion going on, captured at MedCityNews:

If you listen to people discuss mobile health and digital health, they are talking about the same thing. But it’s not just about semantics. It’s around mindset. People aren’t investing in or creating products that make great iPhone apps, they’re primarily seeking the best solutions to leverage data for everything from genomics to telemedicine. All of those will eventually have an app-based solution (or they may begin there), but the aim is to leverage all things D (as in data and digital).

PGXL’s PerMIT software, currently headed into clinical trials, is designed to help physicians properly dose warfarin patients, speeding (we think, the trials will tell) the time to optimal INR and reducing the risk of bleeding. We developed PerMIT as a web-based technology, but what is clear now is that adopting it for mobile is going to be mandatory before going to market.

Chris Seper at MedCityNews favors bundling “mobile” under the digital umbrella, and we’re on board with that. PerMIT is becoming a website, an app, a module that can be plugged into third-party EMR software. The key is to ease physicians’ adoption of genetic information into real-world medical practice. Since it matters not what platform transmits the guidance, “digital” is the way to think about it.